A First in Human Study of STT-5058, an Antibody That Binds ApoC3
Clinical trial NCT04419688 · TERMINATED
Trial details
- NCT number
- NCT04419688
- Sponsor
- Staten Biotechnology BV
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2022-12-23
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.